Dr Keith Thompson has been working at the AO Research Institute Davos (ARI) since 2015, and is currently a member of both the Bone Focus Area and the Musculoskeletal Infection Program.
He completed his bachelor degree in Pharmacology at the University of Aberdeen in 1998, where he subsequently completed a masters degree in Toxicology in 1999. Between 2000 and 2003 he conducted his doctoral studies in the field of antiresorptive bisphosphonate drugs and osteoclast biology, also at the University of Aberdeen. In 2006 he was awarded an Arthritis Research UK Traveling Fellowship to visit the laboratory of Jack Martin and Matthew Gillespie at St. Vincent's Institute in Melbourne. Upon returning to the University of Aberdeen in 2008 he was awarded an Arthritis Research UK Non-Clinical Career Development Fellowship, the aim of which was to gain new insights into the interactions between immune cells and resident bone cells in both normal and chronic inflammatory disease states.
His current research interests include immunomodulatory approaches to enhance bone healing, and a wider interest in immunotherapeutic strategies aimed at promoting tissue regeneration and the prevention of bacterial infections.